3/7/25 16:05 | 3/5/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.d | -1,129 | 15.91 | 0 | -71 | -59 | 48 | D | | | | | | | | | | | | | | |
3/6/25 16:06 | 3/4/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.dm | -2,217 | 15.80 | 0 | -140 | -59 | 97 | D | | | | | | | | | | | | | | |
3/5/25 16:12 | 3/3/25 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.dm | -999 | 16.06 | 0 | -62 | -100 | 0 | D | | | | | | | | | | | | | | |
8/13/24 16:09 | 8/12/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S | -1,711 | 17.30 | 0 | -99 | -100 | 0 | D | | | | | | | | | | | | | | |
3/7/24 16:20 | 3/5/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.d | -657 | 13.52 | 0 | -49 | -33 | 99 | D | | | | | | | | | | | | | | |
3/5/24 16:21 | 3/4/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.d | -1,277 | 13.34 | 0 | -96 | -58 | 70 | D | | | | | | | | | | | | | | |
3/1/24 06:43 | 2/28/24 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.d | -270 | 13.12 | 0 | -21 | -23 | 70 | D | | | | | | | | | | | | | | |
3/8/23 16:02 | 3/6/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.m | -688 | 9.55 | 0 | -72 | -51 | 70 | D | | | | | | | | | | | | | | |
3/2/23 07:33 | 2/28/23 | TEVA | Teva Pharmaceutical Industries Ltd | L3 | Health | Drug | Pharmaceutical Preparations | Daniell Richard | L3 | O | EVP,Euro | S.d | -438 | 9.89 | 0 | -44 | -39 | 70 | D | | | | | | | | | | | | | | |